chartexchange

Relay Therapeutics to Participate in Three Upcoming Investor Conferences in November

GlobeNewswire Inc. | Nov 2, 2026 4:05 PM EST

CAMBRIDGE, Mass., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage, small molecule precision medicine company developing potentially life-changing therapies for patients living with cancer and genetic disease, today announced that management will participate in three upcoming fireside chats in November:

Read original article